Cord Blood is focused on continually improving the balance sheet and becoming cash flow positive. Recently, the company retired $650,000 of Registered Convertible Debt to meet its goals.
The CEO of Cord Blood stated, “This is a major milestone for Cord Blood America. As we have previously stated, we intend that new debts will be serviced by cash flow from existing business or from an acquisition. We are focused on growing the business through organic growth, accretive acquisitions, and intelligent management, with the goal of becoming cash flow positive and continually improving the balance sheet.
The company has also taken other steps to meet its goal such as lower operational loss, increase revenue, and halve the basic and diluted loss per share.
Let us hear your thoughts below:
